Smithbridge Asset Management Inc Regeneron Pharmaceuticals, Inc. Transaction History
Smithbridge Asset Management Inc
- $483 Million
- Q1 2024
A detailed history of Smithbridge Asset Management Inc transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Smithbridge Asset Management Inc holds 3,875 shares of REGN stock, worth $3.8 Million. This represents 0.77% of its overall portfolio holdings.
Number of Shares
3,875
Previous 4,072
4.84%
Holding current value
$3.8 Million
Previous $3.58 Million
4.28%
% of portfolio
0.77%
Previous 0.81%
Shares
7 transactions
Others Institutions Holding REGN
# of Institutions
1,426Shares Held
82.1MCall Options Held
835KPut Options Held
1.46M-
Vanguard Group Inc Valley Forge, PA8.93MShares$8.75 Billion0.17% of portfolio
-
Black Rock Inc. New York, NY8.57MShares$8.4 Billion0.19% of portfolio
-
Jpmorgan Chase & CO New York, NY7.73MShares$7.57 Billion0.68% of portfolio
-
State Street Corp Boston, MA4.84MShares$4.75 Billion0.21% of portfolio
-
Capital World Investors Los Angeles, CA4.65MShares$4.56 Billion0.76% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $105B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...